While low-redundancy (2X) whole genome sequencing of mammals has provided a broad resource for scientists interested in comparative human genome annotation, there are limits to its utility. For example, if an organism is an experimental biomedical model system, the community will often require a high-quality genome assembly.
Further information on this initiative is available in the white paper see: Increasing sequence coverage from 2x to high coverage (6-7x) for selected mammalian species.
For an updated list of the genomes that are actively being sequenced or that have been completed recently, please see Approved Sequencing Targets.
Adam Felsenfeld, Ph.D.
Jane Peterson, Ph.D.
Associate Director, Division of Extramural Research
Last Reviewed: June 13, 2012